ESR1 and breast cancer: N stage, stage, surgery type (breast and axillary surgery type), PNI, LVI, subgroup, ER and PR positivity, HG, duration of anti-hormonal therapy, duration of TAM and AI use, RT type, CT type, recurrence/metastasis rates and mortality rates were significantly different in the Invasive Lobular Special Type BC group (Table 3).